MyCural Therapeutics AB
Developing novel small molecule therapies targeting the MYC oncoprotein.
Overview
- 10–19
- Employees
- 500–749K SEK
- Revenue
- 2022
- Founded
Key Decision Makers
Gunilla Ekström
Board Member
Pernilla Sandwall
Board Member
Dr. Alina Castell
CEO
Ann-Charlotte Rosendahl
Chair of the Board
+8 more contacts in Funnelfeedr
Description
MyCural Therapeutics AB is a life science start-up company focused on advancing high-risk cancer therapies. The organization was founded by cancer researchers affiliated with major Swedish universities, including Karolinska Institutet. Their primary mission is to develop potential candidate drugs th...